XML 61 R31.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Stockholders' Equity (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2016
Stockholders' Equity Note [Abstract] |
Summary of Warrant Activity | A summary of warrant activity was as follows:
| Warrants Outstanding |  | Weighted Average Exercise Price During Period
Balance, December 31, 2013 | 1,107,549 |  |  | $ | 4.41 |
Warrants issued | 147,000 |  |  | 4.65 |
Warrants expired | (285,000 | ) |  | 3.87 |
Balance, December 31, 2014 | 969,549 |  |  | 4.61 |
Warrants exercised | (638,189 | ) |  | 4.58 |
Warrants cancelled/forfeited | (112,110 | ) |  | 5.54 |
Warrants expired | (205,000 | ) |  | 4.20 |
Balance, December 31, 2015 | 14,250 |  |  | 4.30 |
Warrants cancelled/forfeited | (7,500 | ) |  | 4.30 |
Balance, December 31, 2016 | 6,750 |  |  | $ | 4.30 |
Exercisable, December 31, 2016 | — |  |  | $ | — |
Schedule of Warrants | The number of warrants and weighted average remaining life (in years) by price for outstanding and exercisable warrants at December 31, 2016 was as follows:
WARRANTS OUTSTANDING |  | WARRANTS EXERCISABLE
Exercise Price |  | Number of Shares Outstanding |  | Weighted Average Remaining Contractual Life |  | Number of Shares Exercisable |  | Weighted Average Exercise Price
$ | 4.30 |  |  | 6,750 |  |  | 1.07 years |  | — |  |  | $ | — |
Summary of Impact of Results of Stock-Based Compensation | The impact on our results for stock-based compensation was as follows (in thousands):
| For the year ended December 31,
| 2016 |  | 2015 |  | 2014
Cost of sales | $ | 56 |  |  | $ | 38 |  |  | $ | 14 |
Product development | 84 |  |  | 37 |  |  | 8 |
Selling, general, and administrative | 1,220 |  |  | 738 |  |  | 510 |
Total stock-based compensation | $ | 1,360 |  |  | $ | 813 |  |  | $ | 532 |
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions | Estimates utilized in the calculation include the expected life of the option, risk-free interest rate, and expected volatility, and are further comparatively detailed as follows:
| 2016 |  | 2015 |  | 2014
Fair value of options issued | $ | 5.27 |  |  | $ | 5.33 |  |  | $ | 3.62 |
Exercise price | $ | 7.46 |  |  | $ | 7.23 |  |  | $ | 4.69 |
Expected life of option (in years) | 5.8 |  |  | 5.8 |  |  | 5.7 |
Risk-free interest rate | 1.5 | % |  | 1.7 | % |  | 1.8 | %
Expected volatility | 93.7 | % |  | 90.7 | % |  | 97.9 | %
Dividend yield | 0.00 | % |  | 0.00 | % |  | 0.00 | %
Summary of Option Activity | A summary of option activity under all plans was as follows:
| Number of Options |  | Weighted Average Exercise Price Per Share
Outstanding at December 31, 2013 | 286,188 |  |  | $ | 15.30 |
Granted | 326,250 |  |  | 4.76 |
Cancelled | (145,873 | ) |  | 12.38 |
Exercised | (7,294 | ) |  | 2.30 |
Outstanding at December 31, 2014 | 459,271 |  |  | 8.95 |
Granted | 340,500 |  |  | 8.65 |
Cancelled | (147,152 | ) |  | 10.10 |
Exercised | (50,412 | ) |  | 4.69 |
Outstanding at December 31, 2015 | 602,207 |  |  | 8.58 |
Granted | 167,819 |  |  | 7.31 |
Cancelled | (160,126 | ) |  | 12.94 |
Exercised | (79,166 | ) |  | 4.48 |
Outstanding at December 31, 2016 | 530,734 |  |  | $ | 7.48 |
Vested and expected to vest at December 31, 2016 | 513,052 |  |  | $ | 7.50 |
Exercisable at December 31, 2016 | 389,748 |  |  | $ | 7.75 |
Schedule of Options Outstanding | The options outstanding at December 31, 2016 have been segregated into ranges for additional disclosure as follows:
OPTIONS OUTSTANDING |  | OPTIONS EXERCISABLE
Range of Exercise Prices |  | Number of Shares Outstanding |  | Weighted Average Remaining Contractual Life (in years) |  | Weighted Average Exercise Price |  | Number of Shares Exercisable |  | Weighted Average Remaining Contractual Life (in years) |  | Weighted Average Exercise Price
$2.30 | — | $4.00 |  | 46,164 |  |  | 6.3 |  | $ | 2.30 |  |  | 46,164 |  |  | 6.3 |  | $ | 2.30 |
$4.01 | — | $4.45 |  | 107,986 |  |  | 7.1 |  | 4.10 |  |  | 107,192 |  |  | 7.1 |  | 4.10 |
$4.46 | — | $5.48 |  | 136,450 |  |  | 8.1 |  | 5.40 |  |  | 93,741 |  |  | 8.0 |  | 5.36 |
$5.49 | — | $13.58 |  | 168,467 |  |  | 8.2 |  | 7.73 |  |  | 73,623 |  |  | 6.9 |  | 8.57 |
$13.59 | — | $63.60 |  | 71,667 |  |  | 7.1 |  | 19.28 |  |  | 69,028 |  |  | 7.0 |  | 19.44 |
|  |  |  | 530,734 |  |  | 7.6 |  | $ | 7.48 |  |  | 389,748 |  |  | 7.2 |  | $ | 7.75 |
Summary of Restricted Stock Activity | The following table shows a summary of restricted stock and restricted stock unit activity:
| Restricted Stock Outstanding |  | Restricted Stock Units Outstanding |  | Weighted Average Grant Date Fair Value
At December 31, 2013 | 35,869 |  |  | 3,659 |  |  | 7.31 |
Granted | — |  |  | — |  |  | — |
Vested | (35,869 | ) |  | (1,220 | ) |  | 7.20 |
Forfeited | — |  |  | (2,439 | ) |  | 4.10 |
At December 31, 2014 | — |  |  | — |  |  | — |
Granted | — |  |  | 73,750 |  |  | 6.92 |
Forfeited | — |  |  | (16,250 | ) |  | 5.54 |
At December 31, 2015 | — |  |  | 57,500 |  |  | $ | 7.31 |
Granted | — |  |  | 290,966 |  |  | 6.56 |
Vested | — |  |  | (11,213 | ) |  | 14.18 |
Forfeited | — |  |  | (87,138 | ) |  | 6.73 |
At December 31, 2016 | — |  |  | 250,115 |  |  | $ | 6.34 |

X
- Definition Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number of fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term for both options (or share units) currently outstanding and options (or share units) exercisable (or convertible). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration